Healthcare technology firm Covidien of Dublin, Ireland, has inked an agreement with the Institute of Atomic Energy in Poland (IAE Polatom) to augment Covidien's supply of molybdenum-99 (Mo-99), used in the production of the medical isotope technetium-99m (Tc-99m).
The addition of IAE Polatom's Maria research reactor is expected to help Covidien meet the needs of more than 1 million additional patients globally in the first six months after the reactor begins supplying the isotope.
IAE Polatom recently made adjustments to its reactor for medical isotope production and completed a successful test of the manufacturing process this week. "The targets were subsequently processed by our facility in the Netherlands and everything went better than anticipated," said Elaine Haynes, vice president of commercial operations for Covidien's imaging business.
As soon as regulatory hurdles are cleared in Europe, Covidien plans to begin manufacturing and distributing medical isotopes within 30 days.
Haynes said the company currently is working with the U.S. Food and Drug Administration (FDA) to use Mo-99 from the Maria reactor in the U.S. While there is no specific date for supplies to arrive in the U.S., Haynes said, the additional supply in Europe will have a ripple effect in the U.S.
"As soon as we are able to use [Mo-99] in Europe, it begins benefiting the U.S., because we can use the Maria Mo-99 to free up supply from our other sources for Mo-99 for U.S. patients," she said.
Covidien also is seeking similar clearance from Health Canada for use of the medical isotope in that country as well.
The agreement comes two days before Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) is scheduled to close its High Flux Reactor in Petten, Netherlands, for six months for scheduled repairs.
Covidien will continue to get Mo-99 from current contracts with the BR2 reactor in Belgium, the Osiris reactor in France, and the Safari reactor in South Africa.
IAE Polatom's Maria research reactor is located approximately 20 miles southeast of Warsaw. It first began operations in 1975 and was taken offline in 1985 for a complete redesign. It resumed normal operations in 1993.
By Wayne Forrest
AuntMinnie.com staff writer
February 17, 2010
Related Reading
Covidien to halt generator production, January 22, 2010
Covidien pharmaceutical sales dip in fiscal Q1, January 20, 2010
Covidien to sell radiopharmacy business, December 17, 2009
Covidien shows mixed results in Q4, fiscal 2009, November 20, 2009
Covidien to modify Optimark labeling, November 9, 2009
Copyright © 2010 AuntMinnie.com
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
